Biomarker in Colorectal Cancer.

Abstract excerpt

In the last 20 years, improvements in metastatic colorectal cancer treatment lead to a radical raise of outcomes with median survival reaching now more than 30 months. Despite that, the identification of predictive and/or prognostic biomarker still represents a challenging issue, and until today, although clinician and researchers might face with a deeper knowledge of biological mechanisms related to colorectal...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Colorectal Neoplasms
• Share to Microsatellite Instability